Advanced search
Publication Cover
Epigenomics Volume 14, 2022 - Issue 3
Submit an article Journal homepage
66
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Combination Therapy and Noncoding RNAs: A New Era of Cancer Personalized Medicine

Perla Pucci1 Department of Pathology, Division of Cellular & Molecular Pathology, University of Cambridge, Cambridge, CB2 0QQ, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1264-3487
ORCID Icon
Pages 117-120 | Received 19 Oct 2021, Accepted 08 Nov 2021, Published online: 02 Dec 2021

References

  • Leucci E , VendraminR , SpinazziMet al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature531(7595), 518–522 (2016).
  • Winkle M , El-DalySM , FabbriM , CalinGA. Noncoding RNA therapeutics – challenges and potential solutions. Nat. Rev. Drug Discov.20(8), 629–651 (2021).
  • Pucci P , RescignoP , SumanasuriyaS , de BonoJ , CreaF. Hypoxia and noncoding RNAs in taxane resistance. Trends Pharmacol. Sci.39(8), 695–709 (2018).
  • Pencheva N , TranH , BussCet al. Convergent multi-miRNA targeting of ApoE grives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell151(5), 1068–1082 (2012).
  • Tasaki Y , SuzukiM , KatsushimaKet al. Cancer-specific targeting of taurine-upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer. Cancer Res.81(7), 1654–1666 (2021).
  • Pucci P , VenalainenE , AlborelliIet al. LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics12(13), 1123–1138 (2020).
  • Zhen S , LuJ , ChenW , ZhaoL , LiX. Synergistic antitumor effect on bladder cancer by rational combination of programmed cell death 1 blockade and CRISPR-Cas9-mediated long non-coding RNA urothelial carcinoma associated 1 knockout. Hum. Gene Ther.29(12), 1352–1363 (2018).
  • Xue W , DahlmanJE , TammelaTet al. Small RNA combination therapy for lung cancer. PNAS USA111(34), E3553–E3561 (2014).
  • Li Y , JiaF , DengXet al. Combinatorial miRNA-34a replenishment and irinotecan delivery: via auto-fluorescent polymeric hybrid micelles for synchronous colorectal cancer theranostics. Biomater. Sci.8(24), 7132–7144 (2020).
  • Lo YL , WangCS , ChenYCet al. Mitochondrion-directed nanoparticles loaded with a natural compound and a microrna for promoting cancer cell death via the modulation of tumor metabolism and mitochondrial dynamics. Pharmaceutics12(8), 1–23 (2020).
  • Jia F , LiY , DengXet al. Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics. J. Nanobiotechnol.19(1), 1–15 ( 2021).
  • Yue R , ChenM , MaN. Dual microRNA-triggered drug release system for combined chemotherapy and gene therapy with logic operation. ACS Appl. Mater. Interfaces12(29), 32493–32502 (2020).
  • Hong DS , KangYK , BoradMet al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumors. Br. J. Cancer122(11), 1630–1637 (2020).
  • Leyten GHJM , HesselsD , JanninkSAet al. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Eur. Urol.65(3), 534–542 (2014).
  • US National Library of Medicine. Clinical Trials.gov – clinical evaluation of the PROGENSA (registered trademark) prostate cancer gene 3 (PCA3) assay in men with a previous negative biopsy result (PCA3) (2019) https://clinicaltrials.gov/ct2/show/NCT01024959
  • Vernon M , LambertB , Meryet-FiguièreMet al. Functional miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and reveals a new therapeutic combination strategy in ovarian tumor organoids. Mol. Cancer Ther.19(7), 1506–1519 (2020).
  • Tseng YY , MoriarityBS , GongWet al. PVT1 dependence in cancer with MYC copy-number increase. Nature512(1), 82–86 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.